Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
dc.contributor.authorOURGHANLIAN, C.
dc.contributor.authorLAPIDUS, N.
dc.contributor.authorANTIGNAC, M.
dc.contributor.authorFERNANDEZ, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDUMARTIN, Catherine
dc.contributor.authorHINDLET, P.
dc.date.accessioned2021-02-09T13:45:21Z
dc.date.available2021-02-09T13:45:21Z
dc.date.issued2020
dc.identifier.issn2213-7165en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26191
dc.description.abstractEnObjectives Antimicrobial stewardship (AMS) teams around the world include pharmacists; however, their impact is relatively unknown. This study aimed to explore the relationship between pharmacists’ actions and antibiotic consumption. Methods Hospital pharmacists involved in the French antibiotic consumption surveillance network (ATB-Raisin) were invited to participate in a retrospective observational multicentre study. Collected data were: the previous year’s (2016) antibiotic consumption expressed in daily defined dose per 1000 patient-days; AMS measures, including pharmacist-specific actions; and use of a computerised prescription order entry (CPOE) system. Associations between antibiotic consumption and AMS measures were assessed by linear regression, after adjustment for hospital activities. Results Annual data for 2016 from 77 hospitals (7 260 000 bed-days in 24 000 beds) were analysed. Pharmacists were involved in AMS programs in 73% of hospitals, and were the antibiotic advisor in 25%. Pharmaceutical review of prescriptions was organised in almost all hospitals (97%). The univariable analysis identified five measures associated with lower overall antibiotic consumption: CPOE use (if >80% of prescriptions or 100%), pharmaceutical review (if >80% of beds or 100%) and the antibiotic advisor being a pharmacist (P = 0.04, P = 0.004 and P = 0.003, respectively). In the multivariable analysis, two explanatory variables were significantly and independently associated with a lower overall antibiotic consumption: the antibiotic advisor being a pharmacist and a pharmaceutical review covering all beds (–19.9% [–31.6%; –8.1%], P = 0.002 and –18.3% [–34.0%; –2.6%], P = 0.03, respectively). Conclusions Antibiotic consumption was lower when the antibiotic advisor was a pharmacist and when the pharmaceutical team reviewed all prescriptions. These results highlight that actions initiated by pharmacists have a positive impact and should be supported.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectPharmacoEpi-Drugs
dc.title.enPharmacists' role in antimicrobial stewardship and relationship with antibiotic consumption in hospitals: An observational multicentre study
dc.title.alternativeJ Glob Antimicrob Resisten_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jgar.2019.07.009en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed31323427en_US
bordeaux.journalJournal of Global Antimicrobial Resistanceen_US
bordeaux.page131-134en_US
bordeaux.volume20en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Global%20Antimicrobial%20Resistance&rft.date=2020&rft.volume=20&rft.spage=131-134&rft.epage=131-134&rft.eissn=2213-7165&rft.issn=2213-7165&rft.au=OURGHANLIAN,%20C.&LAPIDUS,%20N.&ANTIGNAC,%20M.&FERNANDEZ,%20C.&DUMARTIN,%20Catherine&rft.genre=article


Archivos en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem